TEM · Tempus AI, Inc.
The AI's read
The fees can give Tempus a steadier stream of customer income across current and future products. The annual spending target is $40 million, but that is a target, not the yearly minimum. AstraZeneca can still end the agreement, yet must pay any shortfall against its total commitment.